Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child

Journal of Clinical Virology

Volumn 40, Issue 2, 2007, Pages 152-155

  Iwasenko, Jenna M ^a   Scott, Gillian M ^a   Ziegler, John B ^a,c   Rawlinson, William D ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b New South Wales Government   (Australia)

^c SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Antiviral resistance; Cytomegalovirus; SCID

Indexed keywords

FOSCARNET; GANCICLOVIR;

ARTICLE; BLOOD EXAMINATION; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; COMBINED IMMUNODEFICIENCY; CYTOMEGALOVIRUS INFECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT RECIPIENT; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPROMISED PATIENT; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETREATMENT; TREATMENT DURATION; URINALYSIS; VIRUS RESISTANCE; VIRUS STRAIN;

ANTIVIRAL AGENTS; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG MONITORING; DRUG RESISTANCE, MULTIPLE, VIRAL; FOSCARNET; GANCICLOVIR; HUMANS; IMMUNOCOMPROMISED HOST; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; X-LINKED COMBINED IMMUNODEFICIENCY DISEASES;

EID: 34548676793     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.07.003     Document Type: Article

References (17)

1. Alford C.A., Stagno S., Pass R.F., and Britt W.J. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 12 Suppl 7 (1990) S745-S753
2. Baldanti F., Underwood M.R., Stanat S.C., Biron K.K., Chou S., Sarasini A., et al. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J Virol 70 3 (1996) 1390-1395
3. Blackman S.C., Lurain N.S., Witte D.P., Filipovich A.H., Groen P., and Schleiss M.R. Emergence and compartmentalisation of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency. J Pediatr Hematol Oncol 26 (2004) 601-605
4. Chou S. Antiviral drug resistance in human cytomegalovirus. Transplant Infect Dis 1 (1999) 105-114
5. Chou S., Lurain N.S., Thompson K.D., Miner R.C., and Drew W.L. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J Infect Dis 188 (2003) 32-39 [erratum appears in J Infect Dis 2004 September 15;190(6):1202]
6. Cihlar T., Fuller M.D., and Cherrington J.M. Characterisation of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. J Virol 72 7 (1998) 5927-5936
7. Cihlar T., Fuller M.D., Mulato A.S., and Cherrington J.M. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture. Virology 248 2 (1998) 382-393
8. Gilbert C., and Boivin G. Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother 49 (2005) 873-883
9. Hamprecht K., Eckle T., Prix L., Faul C., Einsele H., and Jahn G. Ganciclovir-resistant cytomegalovirus disease after allogenic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain. J Infect Dis 187 (2003) 139-143
10. Limaye A.P., Bakthavatsalam R., Kim H.W., Kuhr C.S., Halldorson J.B., Healey P.J., et al. Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis. Transplantation 78 (2004) 1390-1396
11. Munro S.C., Hall B., Whybin L.R., Leader L., Robertson P., Maine G.T., et al. Cytomegalovirus diagnosis and screening in pregnant women. J Clin Microbiol 43 (2005) 4713-4718
12. Munro S.C., Trincado D., Hall B., and Rawlinson W.D. Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paediatr Child Health 41 (2005) 449-452
13. Revello M.G., and Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 15 (2002) 680-715
14. Scott G.M., Isaacs M.A., Zeng F., Kesson A.M., and Rawlinson W.D. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. J Med Virol 74 1 (2004) 85-93
15. Scott G.M., Weinberg A., Rawlinson W.D., and Chou S. Multi-drug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates. Antimicrob Agents Chemother 51 (2007) 89-94
16. Springer K.L., Chou S., Li S., Giller R.H., Quinones R., Shira J.E., et al. How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. J Clin Microbiol 43 (2005) 208-213
17. Wolf D.G., Yaniv I., Ashkenazi S., and Honigman A. Emergence of multiple human cytomegalovirus ganciclovir-resistant mutants with deletions and substitutions within the UL97 gene in a patient with severe combined immunodeficiency. Antimicrob Agents Chemother 45 2 (2001) 593-595